These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17657603)

  • 41. Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients.
    Nishiura R; Fujimoto S; Sato Y; Yamada K; Hisanaga S; Hara S; Nakao H; Kitamura K
    Am J Nephrol; 2009; 29(3):257-63. PubMed ID: 18802328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are metalloproteins and acute phase reactants associated with cardiovascular disease in end-stage renal failure?
    Healy H; Reith D; Morgan C; Clague A; Westhuyzen J
    Ann Clin Lab Sci; 2000 Jul; 30(3):295-304. PubMed ID: 10945571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
    Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carotid intima-media thickness in maintenance hemodialysis patients: role of cardiovascular risk factor.
    Ossareh S; Alaei A; Saedi D
    Iran J Kidney Dis; 2011 Jul; 5(3):169-74. PubMed ID: 21525576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
    Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
    Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.
    Ishimura E; Okuno S; Yamakawa T; Inaba M; Nishizawa Y
    Magnes Res; 2007 Dec; 20(4):237-44. PubMed ID: 18271493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
    Rasmussen LE; Svensson M; Jørgensen KA; Schmidt EB; Christensen JH
    Nutr Res; 2010 Aug; 30(8):535-40. PubMed ID: 20851307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
    Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
    Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum albumin fragmentation in end-stage renal disease patients--a pilot study.
    Donadio E; Piccolomini F; Dimuccio V; Felicioli A; Balestreri E; Cianti R; Armini A; Bini L; Felicioli R; Donadio C
    Clin Chem Lab Med; 2009; 47(11):1373-9. PubMed ID: 19778290
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
    Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
    Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients.
    Righetti M; Serbelloni P; Milani S; Ferrario G
    Blood Purif; 2006; 24(4):379-86. PubMed ID: 16755160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High sensitivity T troponin and CA-125 as prognostic biomarkers in patients with end stage renal disease in hemodialysis].
    Moreno JS; Lépori AJ; Novoa P; De Elia R; Guglielmone R; Bono JP
    Rev Fac Cien Med Univ Nac Cordoba; 2016; 73(1):8-14. PubMed ID: 27419890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AGEs and cardiovascular diseases in patients with end-stage renal diseases.
    Nishizawa Y; Koyama H; Inaba M
    J Ren Nutr; 2012 Jan; 22(1):128-33. PubMed ID: 22200429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dialysis vintage and cardiovascular injury as factors influencing long-term survival in peritoneal dialysis and hemodialysis.
    Hoppe K; Schwermer K; Olewicz-Gawlik A; Klysz P; Kawka A; Baum E; Sikorska D; Ścigacz K; Roszak M; Lindholm B; Pawlaczyk K; Oko A
    Adv Clin Exp Med; 2017; 26(2):251-258. PubMed ID: 28791842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum levels of omentin in end-stage renal disease patients.
    Alcelik A; Tosun M; Ozlu MF; Eroglu M; Aktas G; Kemahli E; Savli H; Yazici M
    Kidney Blood Press Res; 2012; 35(6):511-6. PubMed ID: 22813935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T; Miyamae M; Tomonaga O; Omori Y
    Adv Perit Dial; 1996; 12():120-5. PubMed ID: 8865885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kidney transplantation recovers the reduction level of serum sulfatide in ESRD patients via processes correlated to oxidative stress and platelet count.
    Wang L; Kamijo Y; Matsumoto A; Nakajima T; Higuchi M; Kannagi R; Kyogashima M; Aoyama T; Hara A
    Glycoconj J; 2011 May; 28(3-4):125-35. PubMed ID: 21503857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ZAG-a novel biomarker for cardiovascular risk in ESRD patients?
    Schmitt R
    Kidney Int; 2018 Nov; 94(5):858-860. PubMed ID: 30348303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.